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ABSTRACT 
Helical  tomotherapy  (HT)  is  a  novel  treatment  approach  that  combines  Intensity-Modulate  Radiation  Therapy 
(IMRT) delivery with in-built image guidance using megavoltage (MV) CT scanning. The technique utilises a 6 MV 
linear accelerator mounted on a CT type ring gantry. The beam is collimated to a fan beam, which is intensity modulated 
using a binary multileaf collimator (MLC). As the patient advances slowly through the ring gantry, the linac rotates 
around the patient with a leaf-opening pattern optimised to deliver a highly conformal dose distribution to the target in 
the helical beam trajectory. The unit also allows the acquisition of MVCT images using the same radiation source 
detuned to reduce its effective energy to 3.5 MV, making the dose required for imaging less than 3 cGy. This paper 
discusses the major features of HT and describes the advantages and disadvantages of this approach in the context of the 
commercial Hi-ART system. © 2007 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Imaging  has  always  been  a  necessary  prerequisite 
for  radiation  therapy.  Presently,  an  intense  interaction 
between these two fields of technology is observed. The 
discovery of X-rays more than a century ago provided 
the  possibility  to  locate  internal  organs  in  the  human 
body and plan radiation delivery with rectangular fields 
using two-dimensional (2D) transmission images up to 
the mid-1970s. 
The introduction of computed tomography (CT) in 
clinical  practice  resulted  in  high  quality  3D  images, 
which  allowed  precise  definition  of  tumour  shape  and 
location.  This  information  motivated  technology 
development, which would allow planning and delivery 
of  radiation  in  a  more  conformal  way  aiming  to  give 
enough  dose  for  disease  elimination  while  sparing 
healthy tissues. 
Technological advances in radiation oncology such 
as  three-dimensional  conformal  radiation  therapy 
(3DCRT)  and  intensity-modulated  radiation  therapy 
(IMRT)  allow  the  shaping  of  the  dose  distributions  in 
patients,  with  a  very  high  degree  of  conformity  and 
precision  [1].  The  application  of  high-dose  gradients 
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provides  opportunities  for  escalating  tumour  doses 
resulting  in  a  better  chance  of  the  elimination  of 
cancerous  cells  while  still  sparing  healthy,  sensitive 
organs.  At  the  same  time,  such  highly  localised  dose 
distributions  may  result  in  a  partial  target  miss  and/or 
risk  of  organ  damage  if  on  the  day  of  treatment  the 
patient setup and/or anatomy are different from that of 
the imaging study used during planning. If changes in the 
patient’s anatomy are not detected, the treatment could 
be compromised [2]. 
Several solutions to correct the position of the target 
immediately  before  (or  during)  treatment  have  been 
developed and clinically implemented including fiducial 
marker implants [3-6], optical positional guidance [7,8], 
MRI  [9],  ultrasound  [6,10-18],  and  daily  CT  imaging 
[10,18-26]. Each of these techniques has some positive 
(better  targeting,  smaller  margins)  and  negative 
(increased  labor  and  cost,  longer  treatment  times) 
features  and  their  detailed  clinical  assessments  with 
respect to specific disease sites are underway. 
In  the  current  literature,  the  term    ‘image-guided 
radiation therapy’ (IGRT) or IG-IMRT is employed to 
refer to newly emerging radiation planning, patient setup 
and  delivery  procedures  that  integrate  image-based 
tumour  definition  methods,  patient  positioning  devices 
and/or radiation delivery guidance tools [27]. IGRT is a 
necessary  companion  of  improved  treatment  planning 
and better radiation delivery. 
Helical  tomotherapy  (HT)  is  a  novel  radiotherapy 
concept  that  combines  elements  from  a  helical  CT 
scanner with a megavoltage (MV) linear accelerator [28-
30]. The idea to include a MV imaging system for setup 
and dose verification was already put forward in 1993 in 
the first publication on helical tomotherapy [31]. In the 
initial  version  of  IGRT  with  on-board  MVCT 
implemented  in  the  commercially  available  Hi-ART 
model, MVCT allows daily patient setup verification and 
repositioning. In the future, MVCT will also be used for 
imaging  patients  followed  by  quick  planning  for  rapid 
treatment  of  emergency  cases  [32]  and  for  real-time 
image collection during treatment delivery [20]. In this 
report, the basic principles of imaging with tomotherapy 
are discussed. In the companion article, we review the 
first results of HT use in clinical practice. 
THE HELICAL TOMOTHERAPY APPROACH TO IGRT 
The major components of the helical tomotherapy 
system are shown schematically in Figure 1. The patient 
is scanned on a diagnostic kilovoltage CT (kVCT) unit 
prior  to  HT  planning  and  all  structures  (gross  tumour 
volume,  planning  target  volume  and  every  sensitive 
organ  that  needs  to  be  protected)  should  be  outlined. 
Patient CT data and structure set are transferred to the 
HT database using DICOM  protocol. This information 
will be used for inverse planning on the planning station 
and  also  as  a  reference  for  image  guidance  on  the 
operator  station  where  the  planning  kVCT  image  is 
compared to the MVCT image taken immediately before 
treatment. Creation of digitally reconstructed radiographs 
is  not  necessary  as  planning  kVCT  images  will  be 
directly compared to MVCT verification images. 
 
Figure 1  The schematic components of the tomotherapy unit. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    3 
    This page number is not 
    for citation purpose 
 
Radiation delivery 
On  the  HT  unit,  a  conventional  6  MV  linear 
accelerator  and  a  detector  array  system  are  mounted 
opposite each other on a ring gantry that continuously 
rotates  during  the  imaging  and  treatment  procedures 
while the couch translates at a constant speed through the 
gantry as schematically shown in Figure 2. The design 
ensures  minimal  gantry  sag  and,  provided  the  unit  is 
properly aligned, the centre of rotation for radiation and 
mechanical components should be within 1 mm [33]. No 
flattening  filter  is  used  and  the  X-ray  beam  with  an 
output of about 10 Gy/min at isocentre is collimated to 
fan  beam  geometry  with  a  width  of  40  cm  and  a  fan 
beam thickness (FBT) variable from a few millimeters to 
50 mm. Orthogonal to the fan beam width is a binary (i.e. 
‘either open or shut‘) multi-leaf collimator (MLC). Its 64 
leaves are divergent with the beam and project to 6.25 
mm width at isocentre. The transit time for the leaves is 
between 20 and 30 ms for the largest fan beam thickness. 
As the unit is specifically designed for IMRT, the leaf 
thickness  (10  cm  tungsten)  is  thicker  than  in  most 
conventional MLCs and the overall shielding of the head 
is  better.  Therefore,  leakage  radiation  to  the  patient  is 
generally  low  despite  being  treated  with  long  beam  at 
times. Jeraj et al found the out-of-field leakage to be less 
than 0.1% [34], which would result in 1% dose to the 
periphery  of  the  patient  even  in  long  and  complex 
treatments [35]. 
For  planning  and  dose  delivery,  the  full  gantry 
rotation is divided into 51 projections. Each projection is 
characterised by its own leaf opening pattern and covers 
an  arc  segment  of  approximately  7°.  The  available 
rotation period may be between 15 and 60 s (typically 
around 20 s). As such, each projection takes between 0.2 
and  1  s  with  all  leaves  shut  for  a  short  time  between 
projections. The delivery assumes constant dose rate of 
the linac and no dose feedback servo is employed in the 
current  system.  The  monitor  chambers  are  a  safety 
feature that will terminate irradiation if the dose rate is 
outside  predetermined  specifications  (typically  +/-  5% 
over 10 s and +/- 50% over 1 s). 
The treatment unit also includes a radiation detector 
system  at  the  beam  exit  side.  This  is  a  Xe-filled 
ionisation chamber array similar to the ones employed in 
older  diagnostic  CT  scanners.  In  practice,  it  is  the 
tungsten septa that interact most with the MV beam and 
the secondary electrons generated in the tungsten easily 
reach the cavities where they are detected. The detector 
system can be used for acquisition of MVCT scans of the 
patient in treatment position. The linear accelerator is de-
tuned  to  3.5  MV  and  the  pulse  repetition  frequency 
decreased to keep the dose delivered to the patient during 
imaging well below 3 cGy. The data acquisition is fast 
enough to determine the dose given in individual linac 
pulses and the detector acquisition  system (DAS) files 
are  a  most  useful  tool  for  commissioning  and  quality 
assurance (QA) of the unit [36]. 
Treatment planning 
A  treatment  file  for  HT  consists  of  some  60,000 
numbers, which specify leaf opening times as a function 
of gantry position and patient location in the gantry. Due 
to this complexity, tomotherapy treatment plans can only 
be  created  in  an  inverse  planning  process.  Patient  CT 
data  and  structure  set  are  transferred  to  the  planning 
station using DICOM protocol. It is important to extend 
the planning CT scan at least 5 cm beyond any potential 
target volume, as the dose delivery  may be performed 
using a 5 cm-wide fan beam. In this case, the ramp up to 
full dose in the target requires the same length as the fan 
beam thickness [37]. The outlining tools in the current 
tomotherapy  software  are  limited  to  contour 
modifications  but  the  structures  themselves  should  be 
created elsewhere. In practice, the number of contours 
must be typically larger than in ‘conventional’ IMRT, as 
no beam directions can be pre-determined. The planner 
chooses  positions  of  the  movable  red  lasers  (usually 
placed on the external marks made during kVCT study), 
which will be used for initial positioning of the patient 
on the treatment couch. The planning process allows the 
specification of multiple targets, which is convenient for 
simultaneous  in-field  boost  delivery  rather  than  a 
conventional treatment course given in multiple phases 
or  for  the  simultaneous  treatment  of  multiple  isolated 
lesions.  Treatment  delivery  and  planning  depends  on 
parameters specific for HT: fan beam thickness (FBT), 
pitch  factor  and  modulation  factor  (MF).  The  FBT  is 
chosen by the operator to achieve a compromise between 
fast  treatment  times  and  dose  modulation  in  the 
superior/inferior direction. A large FBT results in larger 
volumes covered in any projection and a higher central 
axis  dose  output  while  it  reduces  the  scope  for 
conformality  and  detailed  dose  modulation  in 
cranio/caudal  direction  of  the  patient.  As  such,  the 
largest FBT of about 50 mm is likely to be used for total 
body irradiation and mantle type fields while small FBT 
of 10 mm or even less needs to be employed for small 
brain  lesions  [38].  The  output  in  the  fan  beam  drops 
 
Figure 2  Schematic drawing of a helical tomotherapy unit. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    4 
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dramatically below a FBT of 10 mm due to loss of lateral 
electron  equilibrium  and  partial  source  occlusion  – 
therefore, it is unlikely that smaller FBTs will be used 
frequently. A different way to improve the modulation 
capabilities in the superior/inferior direction is the use of 
a small pitch factor. The pitch factor is defined as couch 
movement per rotation in units of the FBT. While it is 
common  to  use  pitch  factors  of  one  or  higher  in 
diagnostic  CT  scanning,  the  pitch  in  HT  is  typically 
between  0.25  and  0.5  resulting  in  overlap  between 
adjacent  rotations  during  the  helical  delivery.  The 
smaller  the  pitch  factor,  the  longer  the  treatment; 
however, a small pitch also improves the capability of 
dose modulation and the ability to deliver high doses per 
fraction. A potential problem with large FBT and large 
pitch is the dose distribution away from the central axis. 
The  beam  divergence  will  cause  variations  in  overlap 
between adjacent rotations, which increase with distance 
from the axis of rotation. This is known as the ‘thread 
effect’. Kissick et al have investigated this question and 
concluded that a pitch factor of 0.86/integer number (e.g., 
0.43, 0.287, 0.215, etc.) minimises the thread effect [39]. 
The  MF  represents  the  ratio  of  maximum  leaf 
opening time to the mean leaf opening time of all MLC 
leaves, which open in a projection. MF is proportional to 
the  overall  treatment  time,  and  with  typical  physical 
constraints  for  the  tomotherapy  delivery,  MFs  can  be 
selected  between  1  and  approximately  6.  A  small  MF 
results  in  short  treatment  times  and  is  adequate  for 
relatively symmetrical targets close to the central axis of 
the patient, e.g., prostate cancer [40]. 
The  calculation  itself  is  based  on  a 
superposition/convolution dose calculation algorithm [41] 
and an iterative least square optimisation process [42]. 
The planning procedure starts with a calculation of the 
dose distribution produced by all beamlets, which deliver 
radiation  to  the  target  followed  by  an  optimisation  of 
opening  times  for  each  leaf  guided  by  precedence, 
importance and penalty factors. The optimisation results 
may be quickly modified using the same pre-calculated 
beamlets and other sets of important and penalty factors. 
Usually, it takes a couple of hours to produce a plan that 
would  satisfy  the  requirements  of  the  radiation 
oncologist. As the tomotherapy environment at present 
does not allow multitasking, it is generally recommended 
for  performing  the  dose  calculation  overnight  when 
multiple calculation tasks can be batched. Figure 3 shows 
 
Figure 3  Planned dose distributions in axial and sagittal views of a medullary carcinoma of the thyroid. Note the 
conformal avoidance of trachea and spinal cord in a patient with microscopic residual disease after 
resecting medullary carcinoma of the thyroid. 
 
Figure 4  Typical photon beam  spectra  of  helical tomotherapy 
for  two  operational  modes:  treatment  mode  and 
MVCT imaging mode. While in the treatment mode, 
the  incident  electron  energy  is  approximately  5.7 
MeV; in MVCT imaging mode, it is reduced to about 
3.5 MeV corresponding to the average photon energies 
of 1.5 MeV and 1.0 MeV, respectively. Reproduced 
from [34] with permission. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    5 
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an example of planned dose distribution for an 82-year-
old  male  patient  with  a  resected  large  medullary 
carcinoma  of  the  thyroid  with  microscopic  residual 
disease  [planning  target  volume  (PTV)  =  1932  cm
3, 
target length in sup/inf direction of 13 cm). A dose of 60 
Gy to 90% of the PTV was prescribed for delivery in 30 
fractions according to the plan where trachea, spinal cord 
and posterior region were considered sensitive structures 
with priority to the sparing of spinal cord and trachea. 
MVCT in helical tomotherapy 
A  patient  is  initially  positioned  on  the  treatment 
couch using external markings made during the planning 
kVCT  imaging.  Then  a  MVCT  is  acquired.  In  the 
imaging mode, the linear accelerator is detuned in order 
to improve the soft tissue contrast in such a way that the 
nominal energy of the incident electron beam is reduced 
to 3.5 MeV; the resulting photon spectrum is compared 
in  Figure  4  with  the  spectrum  for  the  treatment  mode 
[34]. This photon beam is collimated by the jaws to a 
FBT  of  nominally  4  or  5  mm  at  the  isocenter  in 
superior/inferior direction and 40 cm width laterally. Due 
to the use of megavoltage X-rays, a further reduction of 
FBT  will  result  in  only  a  marginal  improvement  in 
spatial  resolution.  Three  modes  of  image  acquisition: 
coarse,  normal  and  fine,  obtained  by  different  pitches 
(couch movement per gantry rotation 12, 8 or 4 mm) are 
available  resulting  in  image  reconstruction  with  inter-
slice distances of 6, 4 and 2 mm. Figure 5 shows MVCT 
images  of  a  head  of  Rando  phantom  taken  in  coarse 
(time  required  to  image  18  cm  in  superior/inferior 
direction in 30 slices was 156.5 s), normal (time required 
to image the same volume in 45 slices was 231.5 s) and 
fine  (time  required  to  image  a  smaller  volume  in  80 
slices was 406.5 s; 80 is the maximum amount of MVCT 
image slices) imaging options. The image reconstruction 
matrix for the field of view of 40 cm is 512 (resulting in 
a 0.78 mm in-plane pixel resolution). The CT detector 
used  in  the  HT  system  has  been  described  in  several 
papers  [20,43,44].  This  arc-shaped  xenon  detector  has 
738  channels,  each  with  two  ionisation  cavities  filled 
with xenon gas and divided by 0.32 mm tungsten septa. 
The detector array has a 110 cm radius of curvature and 
   
(a)  (b)  (c) 
Figure 5  Example  of  coarse  (6  mm  interslice  distance),  normal  (4  mm  interslice  distance)  and  fine  (2  mm 
interslice distance) options for MVCT imaging of the same slice on a tomotherapy unit. 
 
Figure 6  Example of sagittal view of MVCT (green) and kVCT 
(grey) registration. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    6 
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540 out of 738 channels are used for the MVCT image 
reconstruction. The source to axis distance is 85 cm and 
the source to detector distance is 145 cm. 
Usually  the  MVCT  study  is  performed  using  a 
length,  which  covers  the  PTV  and/or  some  specific 
anatomic landmarks suggested by the physician. Figure 6 
shows typical MVCT/kVCT midline sagittal images on 
an image registration display. The current MVCT images 
are visually evaluated and registered with the planning 
kVCT  set  either  automatically  or  manually.  The 
automatic mode of registration uses a mutual information 
algorithm. One may choose alignment by translation in 
three  directions  and  add  roll,  pitch  and  yaw 
displacements as desired. Shifts in superior/inferior and 
anterior/posterior  directions  are  introduced  by  couch 
displacement. Correction in lateral direction is done by 
the radiation therapists using manual fine adjustment on 
the  treatment  couch  within  the  limits  of  2.5  cm.  Roll 
correction is accounted by changing the starting angle for 
gantry rotation [45]. Pitch and yaw corrections can only 
be introduced by moving the patient and these last two 
corrections are performed very rarely in clinical practice 
and only when the other four displacements are not able 
to  provide  sufficient  alignment.  After  automatic 
registration, the alignment of fiducial anatomic features 
as assigned by a radiation oncologist is checked by the 
radiation  therapists  and,  if  necessary,  manual 
adjustments of the patient setup are performed. 
In  principle,  the  field  of  view  (FOV)  of  40  cm 
available in the tomotherapy MVCT system may lead to 
a degradation of image quality because the tissue outside 
the  FOV  is  not  properly  accounted  for  in  the 
reconstruction  process.  The  typical  result  is  ‘bowl’ 
artifacts so regarded because the reconstructed CT values 
are  increased  in  the  peripheral  regions  of  the  images. 
Ruchala et al have shown that the voxel-based mutual 
information algorithm used by tomotherapy software for 
registration  still  provides  successful  automatic 
 
Figure 7  The ‘cheese’ phantom for tomotherapy delivery quality assurance process. Shown is a sheet of EDR2 
film (Eastman Kodak Co. Rochester, NY) on the lower half of the phantom. It will be covered with the 
other half and both half cylinders can be fixed against each other using rubber ties. In the foreground of 
the photo is the Exradin A1SL ion chamber (Standard Imaging, Middleton, WI), which is used to verify 
the absolute dose delivered in at least one of the holes drilled in the phantom. 
 
Figure 8  Typical setup of a ‘patient’ (head of Rando phantom) 
on the top of the film used for in vivo dosimetry on 
tomotherapy unit in London, Ontario, Canada. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    7 
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registration with fields of view down to about one-half of 
a patient’s size and limited-slice images [46]. 
Concerning  setup  uncertainties,  it  is  generally 
accepted that there are two types, systematic and random. 
Systematic uncertainties exist because the acquired 3D 
image may differ from the average target position and 
random uncertainty is the day-to-day deviation from the 
target  average  position  [47].  Boswell  et  al  compared 
automatic  tomotherapy  setup  using  MVCT  to  an 
optically-guided  patient  positioning  system  using  an 
anthropomorphic  head  phantom  and  found  net 
translational differences between the optical camera and 
tomotherapy software automatic registration results to be 
within  2.3  mm  in  878  of  900  registration  trials  [48]. 
Setup corrections for real patients may be much larger 
because alignments of organs vary from day to day: the 
detected  maximum  setup  deviation  was  3  mm  for 
patients  fixated  with  the  body  frame  and  6  mm  for 
patients positioned in the vacuum pillow [49]. 
Performance  characteristics  of  MVCT  on  Hi-Art 
tomotherapy system were reported by Meeks et al [43]. 
They  studied  image  noise  and  uniformity,  spatial 
resolution, contrast properties and multiple scan average 
dose  with  a  Cardinal  Health  AAPM  CT  Performance 
Phantom (Cardinal Health, Hicksville, NY), which is an 
acrylic cylinder  (21.6 cm in diameter and 31.75 cm in 
length) with inserts. The images were very uniform with 
an uniformity index greater than 95% and no statistically 
significant  difference  as  a  function  of  an  equivalent 
reconstruction  matrix  or  pitch.  Typical  noise  standard 
deviations are 2-4%, which are only slightly worse than 
that for diagnostic CT. The visible resolution for the 512 
matrix images was approximately 1.25 mm. The contrast 
resolution  e.g.,  ability  to  distinguish  between  muscle 
tissue  with  electron  density  of  3.44-3.48  (1023 
electrons/cm
3 from the surrounding adipose tissue with 
3.18  (1023  electrons/cm
3)  is  clinically  an  important 
characteristic: in general, the need for high resolution is 
not  as  pressing  as  low-contrast  detectability  [20].  A  
MVCT  scan  with  the  dose  of  1.1  cGy  allows  a  clear 
identification  of  the  prostate  and  rectum  because  their 
electron  densities  are  on  the  order  of  8-10%  different 
from  the  surrounding  region  [43].  By  increasing  the 
imaging dose, it is possible to improve the contrast e.g., 
an 8 cGy scan made it possible to delineate regions with 
the  contrast  about  2%  [20].  This  is  currently  not  an 
option  that  the  user  can  select  in  clinical  mode.  An 
experimental study comparing MVCT with conventional 
diagnostic CT scans in dogs with spontaneous tumours 
concluded that the MVCT image quality is sufficiently 
good to allow three-dimensional setup verification [29]. 
Quality Assurance 
A system of the complexity of a helical tomotherapy 
unit obviously requires a significant amount of QA. At 
present, it is left to the user to determine the level of QA 
as  no  widely  accepted  protocol  for  HT  QA  exists  at 
present.  The  suggestion  of  a  QA  program  for  HT  is 
beyond  the  scope  of  the  present  review:  see  relevant 
publications  [50,51].  The  manufacturer  acknowledges 
the need for patient specific QA and it is suggested that 
the dose distribution for every patient is verified prior to 
treatment.  To  this  end,  a  special  phantom  (‘cheese 
phantom’ shown in Figure 7) and a QA module in the 
planning software is included in the purchase of a HT 
unit. The QA module for planning allows the calculation 
of the dose distribution, which would be achieved if the 
patient plan was delivered onto a phantom of the user’s 
choice. The software is an integral part of the planning 
station, which makes QA a natural flow of the planning 
process. 
The typical QA process requires the user to verify 
the absolute dose to at least one point using an ionisation 
chamber, and the dose distribution in a relevant plane of 
the phantom using radiographic film. After digitisation, 
the  dose  distribution  from  the  film  can  be  directly 
imported  into  the  planning  software  and  quantitative 
comparisons  can  be  made  with  the  verification  plan 
using dose profiles and gamma evaluation [52,53]. 
Recently,  Kron  et  al  have  proposed  an  in  vivo 
quality  assurance  procedure  for  treatments  on  the 
tomotherapy unit [54]. In this method, a film is placed 
between the patient and the couch top during treatment 
as  can  be  seen  with  a  phantom  example  in  Figure  8. 
Tomotherapy  Inc.  provides  a  ‘dose  delivery  quality 
 
(a) 
 
(b) 
Figure 9  Example of in vivo dosimetry using MVCT study as a 
‘phantom’: a) The thin isodose lines represent the dose 
from the in vivo dosimetry film, the thick dotted ones 
are  calculated  for  the  MVCT  data on  the  same  day 
they  were  imported  as  a  phantom  in  the  DQA 
software, b) A dose profile comparison along the line 
shown in (a). S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    8 
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assurance’ (DQA) module, which re-calculates the dose 
distribution  one  would  get  by  delivering  the  patient 
treatment  sequence  onto  a  selected  phantom.  It  is 
possible to import MVCT study performed immediately 
before patient treatment i.e., before the film exposure, as 
a ‘phantom’. This allows calculation of the dose from the 
optimised open leaf sinogram for the same patient and 
utilises the dose comparison tool available in the DQA 
software as illustrated in Figure 9. 
In Table 1, we summarize the principle features of 
helical  tomotherapy  and  compare  them  with 
characteristics of conventional radiotherapy units using 
linear accelerators. In the near future, it is the intent that 
MVCT will be used also for reconstruction of the dose 
actually delivered and for planning and re-planning with 
real-time  image  collection  during  treatment  delivery 
[32,55,56]. 
CONCLUSION 
Helical tomotherapy is a new concept in radiation 
therapy  combining  IMRT  treatment,  3-D  inverse 
treatment  planning  and  3-D  MVCT  imaging  in  one 
integrated machine. All these components are uniquely 
designed  for  IMRT.  The  complexity  of  the  delivery 
process  only  allows  inverse  treatment  planning  but 
delivers highly conformal dose distributions. Treatment 
planning  studies  demonstrate  dose  homogeneity  and 
conformal  avoidance  capabilities  as  two  of  the  major 
strong points of the system. One of the most important 
features of the HT concept is the on-board MVCT image 
acquisition system. It allows not only the verification of 
patient positioning but constitutes a powerful QA tool, 
which ultimately will yield the reconstruction of the dose 
as  it  was  actually  delivered  to  the  patient  on  every 
occasion of a fractionated course of treatment. 
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Table 1  Comparison of helical tomotherapy to conventional linac based radiation therapy (RT)  
Feature  Conventional Linac based RT  Helical Tomotherapy 
Treatment planning  Many commercial systems with different 
features 
Specialised planning system 
Treatment options  From single beam to IMRT 
Electrons and photons 
Only IMRT with photons 
Beam arrangements  •  Different energies possible 
•  Several, typically discrete angles 
•  Two dimensional beams with 
possible beam modifiers such as 
wedges or compensators, or IMRT 
•  Non-coplanar arrangements possible 
•  Only 6 MV photons 
•  360 degree arc 
•  Fan beam – helical delivery with pitch 
factor  < 1 produces extension of fields in 
sup/inf direction 
•  Strictly coplanar 
MLC and intensity 
modulation 
Shapes the field – multiple segments 
with different MLC settings and monitor 
units generate intensity modulated beam 
Binary MLC generates beamlet pattern as 
function of gantry position 
Image guidance  Many variations possible – they include 
kV on board imaging, kV or MV cone 
beam CT and ultrasound. Most of these 
systems are add-ons 
MVCT using the same radiation source as 
the treatment unit 
Commissioning  Depends on features and options  Partially done in factory – depends on 
understanding the system 
QA  Depends on equipment availability  Integral part of the system S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e16    10 
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